ctrl K

Price Alert

Immunome Inc. (IMNM)

NASDAQ: IMNM · Real-Time Price · USD

9.85

-0.40 (-3.90%)

At close: Aug 19, 2025, 11:59 AM

Immunome Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	143.35M	98.68M	20.32M	49.23M
Short-Term Investments	73.95M	39.46M	n/a	n/a
Long-Term Investments	100K	100K	100K	100K
Other Long-Term Assets	4.41M	100K	332K	332K
Receivables	n/a	289K	847K	4.31M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	4.04M	4.99M	n/a	n/a
Total Current Assets	221.34M	144.7M	22.65M	56.64M
Property-Plant & Equipment	14.39M	3.64M	965K	855K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	18.9M	3.84M	1.4M	1.29M
Total Assets	240.24M	148.54M	24.05M	57.92M
Account Payables	14.19M	3.31M	2.4M	3.08M
Deferred Revenue	6.94M	10.49M	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	33.11M	4.98M	1.96M	2.02M
Total Current Liabilities	54.31M	21.83M	7.33M	9.73M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	5.49M	n/a	12K
Total Long-Term Liabilities	4.77M	6.83M	62K	12K
Total Liabilities	59.08M	28.66M	7.39M	9.74M
Total Debt	4.83M	1.65M	291K	317K
Common Stock	6K	4K	1K	1K
Retained Earnings	-515.77M	-222.81M	-116M	-79.11M
Comprehensive Income	57K	22K	n/a	-57.92M
Shareholders Equity	181.16M	119.88M	16.65M	48.19M
Total Investments	73.95M	39.56M	100K	100K